Clinical Research Directory
Browse clinical research sites, groups, and studies.
Cold Agglutinin Disease Real World Evidence Registry
Sponsor: RECORDATI GROUP
Summary
This is a multinational, multi-center, observational, prospective, longitudinal disease registry designed to collect data on participants with cold agglutinin disease (CAD) or cold agglutinin syndrome (CAS). Among them, a minimum of 30 patients with CAD treated with sutimlimab are expected to take part in the sutimlimab cohort study. Patients with CAD who have been enrolled in previous sutimlimab clinical trials (e.g., BIVV009-01/LTS16214 \[NCT02502903,CAD patients\], BIVV009-03/EFC16215 \[NCT03347396\], and BIVV009-04/EFC16216 \[NCT03347422\]) and who either completed or discontinued the corresponding clinical trial are eligible to participate in the registry.
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
400
Start Date
2019-12-12
Completion Date
2028-11-02
Last Updated
2025-11-20
Healthy Volunteers
No
Interventions
Sutimlimab
CAD patients in Sutimlimab cohort must be treated according to routine clinical practice
Locations (68)
University of Alabama at Birmingham Site Number : 1230
Birmingham, Alabama, United States
SLO Oncology and Hematology Site Number : 1235
San Luis Obispo, California, United States
Mission Hope Medical Oncology Site Number : 1241
Santa Maria, California, United States
MedStar Georgetown University Hospital / Lombardi Comprehensive Cancer Center Site Number : 1208
Washington D.C., District of Columbia, United States
Piedmont Cancer Institute, P.C Site Number : 1226
Atlanta, Georgia, United States
Orchard Heathcare Research Inc. Site Number : 1202
Skokie, Illinois, United States
Siouxland Regional Cancer Center dba June E. Nylen Cancer Center Site Number : 1220
Sioux City, Iowa, United States
Reliant Medical Group Site Number : 1205
Worcester, Massachusetts, United States
Henry Ford Hospital Site Number : 1232
Detroit, Michigan, United States
Northwell Health-Monter Cancer Center-North Shore University Hospital and Steven and Alexandra Cohen Children's Medical Center of New York (Schneider Children's Hospital)-North Shore Long Island Jewis Site Number : 1231
Lake Success, New York, United States
Center for Blood Disorders Site Number : 1214
New York, New York, United States
SUNY Upstate Medical University Site Number : 1221
Syracuse, New York, United States
Brody School of Medicine at East Carolina University Site Number : 1203
Greenville, North Carolina, United States
Cleveland Clinic Foundation Site Number : 1207
Cleveland, Ohio, United States
The Ohio State University Site Number : 1236
Columbus, Ohio, United States
Hematology Oncology Associates, PC Site Number : 1211
Medford, Oregon, United States
University of Pittsburgh Medical Center-UPMC Hillman Cancer Center Site Number : 1210
Pittsburgh, Pennsylvania, United States
UT Medical Center Cancer Institute Site Number : 1237
Knoxville, Tennessee, United States
University of Washingtion Seattle Cancer Care Alliance Site Number : 1238
Seattle, Washington, United States
Investigational Site Number : 3101
Salzburg, Austria
Investigational Site Number : 3102
Vienna, Austria
Investigational Site Number : 3222
Amiens, France
Investigational Site Number : 3214
Angers, France
Investigational Site Number : 3204
Cesson-Sévigné, France
Investigational Site Number : 3211
Chalon-sur-Saône, France
Investigational Site Number : 3206
Corbeil-Essonnes, France
Investigational Site Number : 3201
Créteil, France
Investigational Site Number : 3219
Dijon, France
Investigational Site Number : 3221
Epagny-Metz-Tessy, France
Investigational Site Number : 3217
Paris, France
Investigational Site Number : 3213
Pau, France
Investigational Site Number : 3203
Pessac, France
Investigational Site Number : 3216
Poitiers, France
Investigational Site Number : 3202
Quimper, France
Investigational Site Number : 3220
Rennes, France
Investigational Site Number : 3205
Saint-Priest-en-Jarez, France
Investigational Site Number : 3218
Toulouse, France
Investigational Site Number : 3301
Essen, Germany
Investigational Site Number : 3306
Hanover, Germany
Investigational Site Number : 3302
Landshut, Germany
Investigational Site Number : 3413
Brescia, Lombardy, Italy
Investigational Site Number : 3410
Campobasso, Italy
Investigational Site Number : 3403
Novara, Italy
Investigational Site Number : 3411
Palermo, Italy
Investigational Site Number : 3415
Pavia, Italy
Investigational Site Number : 3412
Ravenna, Italy
Investigational Site Number : 3402
Reggio Calabria, Italy
Investigational Site Number : 3404
Roma, Italy
Investigational Site Number : 3405
Terni, Italy
Investigational Site Number : 2203
Fukushima, Fukushima, Japan
Investigational Site Number : 2204
Himeji-shi, Hyōgo, Japan
Investigational Site Number : 3701
Barcelona, Barcelona [Barcelona], Spain
Investigational Site Number : 3712
Madrid, Spain
Investigational Site Number : 3603
Truro, Cornwall, United Kingdom
Investigational Site Number : 3617
Carlisle, Cumbria, United Kingdom
Investigational Site Number : 3608
Gillingham, Kent, United Kingdom
Investigational Site Number : 3605
London, London, City of, United Kingdom
Investigational Site Number : 3602
Salford, Manchester, United Kingdom
Investigational Site Number : 3623
Airdrie, North Lanarkshire, United Kingdom
Investigational Site Number : 3601
Newcastle upon Tyne, North Tyneside, United Kingdom
Investigational Site Number : 3613
Middlesbrough, North Yorkshire, United Kingdom
Investigational Site Number : 3611
Oxford, Oxfordshire, United Kingdom
Investigational Site Number : 3606
Taunton, Somerset, United Kingdom
Investigational Site Number : 3618
Birmingham, United Kingdom
Investigational Site Number : 3620
Harrow, United Kingdom
Investigational Site Number : 3612
Leeds, United Kingdom
Investigational Site Number : 3607
Liverpool, United Kingdom
Investigational Site Number : 3621
London, United Kingdom